The University of Edinburgh is a public research university in Edinburgh, Scotland. Granted a royal charter by King James VI in 1582 and officially opened in 1583, it is one of Scotland's four ancient universities and the sixth-oldest university in continuous operation in the English-speaking world.

During the past decade, University of Edinburgh conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 4 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 4 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Edinburgh" #1 sponsor was "University of Edinburgh" with 39 trials, followed by "Biogen" with 2 trials sponsored, "Altitude Physiology Expeditions" with 1 trials sponsored, "Anavex Life Sciences Corp." with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Edinburgh" #1 collaborator was "NHS Lothian" with 9 trials as a collaborator, "British Heart Foundation" with 7 trials as a collaborator, "University of Edinburgh" with 4 trials as a collaborator, "Imperial College London" with 3 trials as a collaborator and "University of Glasgow" with 3 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "University of Edinburgh" are "Coronary Artery Disease" (5 trials), "Stroke" (4 trials), "Angina Pectoris" (3 trials), "Heart Failure" (3 trials) and "Myocardial Infarction" (3 trials). Many other conditions were trialed in "University of Edinburgh" in a lesser frequency.

Most popular intervention types in "University of Edinburgh" are "Drug" (20 trials), "Other" (13 trials), "Behavioral" (4 trials), "Diagnostic Test" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "CT-PET scan" (2 trials), "Cardiac MRI scan" (2 trials), "Smoke-free legislation" (2 trials) and "18F-GP1" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Edinburgh" are 60 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Edinburgh". 1 are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in University of Edinburgh, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University of Edinburgh, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 15 trials that are defined as “Not Applicable".

University of Edinburgh has several departments that took part in Clinical trials: "Edinburgh Cancer Research Centre" - 8 trials, "Centre for Cardiovascular Science" - 4 trials, "Edinburgh Dental Institute" - 4 trials, "Centre for Cardiovascular Sciences, University of Edinburgh" - 4 trials, "Edinburgh Centre for Neuro-Oncology, Western General Hospital" - 2 trials, "Western General Hospital; Edinburgh Breast Unit" - 2 trials